Copyright
©2010 Baishideng.
World J Gastrointest Pharmacol Ther. Apr 6, 2010; 1(2): 54-63
Published online Apr 6, 2010. doi: 10.4292/wjgpt.v1.i2.54
Published online Apr 6, 2010. doi: 10.4292/wjgpt.v1.i2.54
Ref. | Type of study | Type of HE/patients (n) | Tested treatment | Control treatment | Results |
Uribe et al[23] 1987 | Double-blind, controlled trial | Episodic overt HE (20) | Lactitol and lactose enemas | Nonacidifying enemas | Acidifying agents like lactose and lactitol are effective and superior to tap-water enemas for the treatment of HE |
Hassanein et al[31] 2007 | Prospective, randomized, controlled, multicenter trial | Severe episodic overt HE (70) | Molecular adsorbent recirculating system (MARS) and standard medical therapy | Standard medical therapy | MARS is associated with an earlier and more frequent improvement of HE |
Kircheis et al[57] 1997 | Randomized, double-blind, placebo-controlled, multicenter trial | MHE (53) and mild overt HE (grade I-II, 53) | L-ornithine-L-aspartate, 20 g/d i.v. | Placebo | Therapy improves psychometric performance and is safe and effective in HE treatment |
Stauch et al[58] 1998 | Randomized, double-blind, placebo-controlled clinical trial | MHE (23) and mild overt HE (43) | L-ornithine-L-aspartate, 9 g/d orally | Placebo | Therapy improves psychometric performance, blood ammonia levels and is safe and effective in HE treatment |
Ahmad et al[59] 2008 | RCT | Overt HE (80) | L-ornithine-L-aspartate, 20 g/d i.v. | Placebo | Treatment improves blood ammonia and mental state |
Sushma et al[62] 1992 | Prospective randomized double-blind study | Overt HE (74) | Sodium Benzoate, 5 g | Lactulose | Improvement in portal-systemic encephalopathy parameters occurred in both treatment groups and was similar |
Reding et al[66] 1984 | Double-blind randomised trial | Chronic HE (22) | Zinc acetate 600 mg/d | Placebo | Treatment improves psychometric performance |
Riggio et al[67] 1991 | Double-blind, crossover trial | Chronic HE (15) | Zinc sulfate 600 mg/d and lactitol | Lactitol | Zinc was significantly raised after oral administration, but no modification in the parameters included in Conn's index were observed |
Loguercio et al[72] 1995 | Double blind parallel trial | HE (40) | SF-68 | Lactulose | SF-68 improves blood ammonia and psychometric performance |
Gentile[75] 2005 | Randomized, double-blind, crossover study | HE (107) | Acarbose 300 mg/d | Placebo | Acarbose improves blood ammonia levels and HE clinical parameters |
- Citation: Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63
- URL: https://www.wjgnet.com/2150-5349/full/v1/i2/54.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v1.i2.54